Growth Factor Signaling for Cardioprotection Against Oxidative Stress-Induced Apoptosis

Antioxidants and Redox Signaling

Volumn 5, Issue 6, 2003, Pages 741-749

  Suzuki, Yuichiro J ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; SCATTER FACTOR; SOMATOMEDIN; TACROLIMUS; TRANSCRIPTION FACTOR GATA 4; TRANSFORMING GROWTH FACTOR;

ACUTE LEUKEMIA; APOPTOSIS; CELL DEATH; DNA BINDING; HEART FAILURE; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0344395647     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603770380043     Document Type: Review

References (78)

1. Abdel-Aleem S, El-Merzabani MM, Sayed-Ahmed M, Taylor DA, and Lowe JE. Acute and chronic effects of Adriamycin on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol 29: 789-797, 1997.
2. Ahmet I, Sawa Y, Iwata K, and Matsuda H. Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: a novel gene therapy for cardiomyopathy. J Thorac Cardiovasc Surg 124: 957-963, 2002.
3. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997.
4. Araki M, Hasegawa K, Iwai-Kanai E, Fujita M, Sawamura T, Kakita T, Wada H, Morimoto T, and Sasayama S. Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes. J Am Coll Cardiol 36: 1411-1418, 2000.
5. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, and Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60: 1789-1792, 2000.
6. Baxter GF, Mocanu MM, Brar BK, Latchman DS, and Yellon DM. Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 38: 930-939, 2001.
7. Bialik S, Greenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, and Kitsis RN. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372, 1997.
8. Blobel GA and Orkin SH. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 16: 1687-1694, 1996.
9. Blobel GA, Sieff CA, and Orkin SH. Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15: 3147-3153, 1995.
10. Bolli R. Mechanism of myocardial "stunning." Circulation 82: 723-738, 1990.
11. Bolli R, Patel BS, Jeroudi MO, Lai EK, and McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 82: 476-485, 1988.
12. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, and Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
13. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, and Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92: 8031-8035, 1995.
14. Bugge E and Ytrehus K. Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. Cardiovasc Res 32: 920-929, 1996.
15. Chen DB, Wang L, and Wang PH. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci 67: 1683-1693, 2000.
16. Doroshow JH and Davies KJA. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem 261: 3068-3074, 1986.
17. Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, and Rosen EM. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17: 131-141, 1998.
18. Fliss H and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956, 1996.
19. Foncea R, Galvez A, Perez V, Morales MP, Calixto A, Melendez J, Gonzalez-Jara F, Diaz-Araya G, Sapag-Hagar M, Sugden PH, LeRoith D, and Lavandero S. Extracellular regulated kinase, but not protein kinase C, is an antiapoptotic signal of insulin-like growth factor-1 on cultured cardiac myocytes. Biochem Biophys Res Commun 273: 736-744, 2000.
20. Froesch ER, Schmid C, Schwander J, and Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 47: 443-467, 1985.
21. Fujio Y, Nguyen T, Wencker D, Kitsis RN, and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667, 2000.
22. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, and Sasayama S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94: 610-613, 1996.
23. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
24. L expression. Blood 94: 87-96, 1999.
25. Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, and Nunez G. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 158: 4750-4757, 1997.
26. Grunenfelder J, Miniati DN, Murata S, Falk V, Hoyt EG, and Robbins RC. Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts. J Heart Lung Transplant 21: 244-250, 2002.
27. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, and Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94: 623-630, 1994.
28. Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS, and Wilson DB. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138: 3505-3514, 1997.
29. Hong F, Kwon SJ, Jhun BS, Kim SS, Ha J, Kim SJ, Sohn NW, Kang C, and Kang I. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 68: 1095-1105, 2001.
30. Horiuchi M, Hayashida W, Kambe T, Yamada T, and Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272: 19022-19026, 1997.
31. Horrigan MC, Maclsaac AI, Nicolini FA, Vince DG, Lee P, Ellis SG, and Topol EJ. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation 94: 1927-1933, 1996.
32. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, and Sasayama S. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 190: 54-62, 2002.
33. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, and Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98: 2065-2073, 1998.
34. Kakita T, Hasegawa K, Iwai-Kanai E, Adachi S, Morimoto T, Wada H, Kawamura T, Yanazume T, and Sasayama S. Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res 88: 1239-1246, 2001.
35. Kang YJ, Chen Y, and Epstein PN. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271: 12610-12616, 1996.
36. Kang YJ, Zhou ZX, Wang GW, Buridi A, and Klein JB. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 275: 13690-13698, 2000.
37. Keinanen R, Vartiainen N, and Koistinaho J. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene 234: 297-305, 1999.
38. Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, and Suzuki YJ. Anthracycline-induced down-regulation of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63: 368-377, 2003.
39. Kitta K, Clément SA, Remeika J, Blumberg JB, and Suzuki YJ. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in HL-1 atrial-muscle cell line. Biochem J 359: 375-380, 2001.
40. Kitta K, Day RM, Ikeda T, and Suzuki YJ. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 31: 902-910, 2001.
41. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, and Suzuki YJ. Hepatocycte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278: 4705-4712, 2003.
42. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, and Mann DL. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 97: 5456-5461, 2000.
43. Lefer AM, Tsao P, Aoki N, and Palladino MA. Mediation of cardioprotection by transforming growth factor-beta. Science 249: 61-64, 1990.
44. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, and Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100: 1991-1999, 1997.
45. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 2: F624-F633, 1999.
46. Liu Y, Sun AM, and Dworkin LD. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 246: 821-826, 1998.
47. Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ, and Rosenzweig A. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100: 2373-2379, 1999.
48. Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, and Sasayama S. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221: 391-395, 1996.
49. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, and Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94: 1506-1512, 1996.
50. Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275: 38949-38952, 2000.
51. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, and Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
52. Morita M, Watanabe Y, and Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585-1593, 1995.
53. Nakamura T, Nawa K, and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459, 1984.
54. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Yashiro K, and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
55. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, and Nakamura T. Myocardial protection from ischemia/ reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106: 1511-1519, 2000.
56. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, and Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene 6: 501-504, 1991.
57. Olson RD and Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076-3086, 1990.
58. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95: 2552-2558, 1997.
59. O'Prey J, Ramsay S, Chambers I, and Harrison PR. Transcriptional up-regulation of the mouse cytosolic glutathione peroxidase gene in erythroid cells is due to a tissue-specific 3′ enhancer containing functionally important CACC/GT motifs and binding sites for GATA and Ets transcription factors. Mol Cell Biol 13: 6290-6303, 1993.
60. Parrizas M, Saltiel AR, and LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinae and mitogen-activated protein kinase pathways. J Biol Chem 272: 154-161, 1997.
61. Ping P, Zhang J, Cao X, Li RCX, Kong K, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, and Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 276: H1468-H1481, 1999.
62. Ren J, Samson WK, and Sowers JR. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31: 2049-2061, 1999.
63. Revoltella RP, Borney F, Dal Canto B, and D'Urso CM. Apoptosis of serum-free C2.8 mouse embryo hepatocytic cells caused by hepatocyte growth factor deprivation. Cytotechnology 13: 13-19, 1993.
64. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, and Sugishita K. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353-355, 1996.
65. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, and Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 95: 320-323, 1997.
66. Sato T, Yoshinouchi T, Sakamoto T, Fujieda H, Murao S, Sato H, Kobayashi H, and Ohe T. Hepatocyte growth factor (HGF): a new biochemical marker for acute myocardial infarction. Heart Vessels 12: 241-246, 1997.
67. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, and Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 272: 5783-5791, 1997.
68. Suzuki T and Miyauchi T. A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes. Am J Physiol 280: R1399-R1406, 2001.
69. Suzuki YJ. Stress-induced activation of GATA-4 in cardiac muscle cells. Free Radic Biol Med 34: 1589-1598, 2003.
70. Tanaka H, Matsumura I, Nakajima K, Daino H, Sonoyama J, Yoshida H, Oritani K, Machii T, Yamamoto M, Hirano T, and Kanadura Y. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and Bcl-2 in a murine myeloid cell line M1. Blood 95: 1264-1273, 2000.
71. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, and Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75: 426-433, 1994.
72. Tanaka T, Mizuno K, Umesaki N, and Ogita S. Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor. Clin Exp Obstet Gynecol 25: 125-128, 1998.
73. Ueda H, Sawa Y, Matsumoto K, Kitagawa-Sakakida S, Kawahiro Y, Nakamura T, Kaneda Y, and Matsuda H. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg 67: 1726-1731, 1999.
74. Ueda H, Nakamura T, Matsumoto K, Sawa Y, Matsuda H, and Nakamura T. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res 51: 41-50, 2001.
75. Wang L, Ma W, Markovich R, Chen JW, and Wang PH. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 83: 516-522, 1998.
76. Weiss M and Orkin S. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A 92: 9623-9627, 1995.
77. Wu W, Lee WL, Wu YY, Chen D, Liu TJ, Jang A, Sharma PM, and Wang PH. Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem 275: 40113-40119, 2000.
78. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, and Webster KA. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88: 609-614, 2001.